Member Briefing: The Supreme Court Decision on Myriad Case

Thursday, June 20 2013
3:00 pm – 4:00 pm

Location: Conference Call

This event will be held as a conference call and the call will be taped. Please register in advance so we can send call-in information to you.

Last week, the U.S. Supreme Court ruled unanimously in Association for Molecular Pathology vs. Myriad Genetics that isolated genomic DNA can not be patented. Join us for a brief call with some initial analysis from some industry experts.


  • Hans Sauer, Associate General Counsel, IP, BIO
  • Gregory D. Williams, Attorney at Law, Pepper Hamilton LLP
  • Konstantin M Linnik, PhD, Partner / Attorney at Law, Nutter McClennen & Fish LLP


****This event will be held as a conference call. Questions can be emailed in advance and during the call to Susan Silberman at with the subject line "Supreme Court Call."  

Questions will be reviewed and posed to the panelists at the end of the panel discussion.

Share MassBio